FDA NDC Directory · JSON-LD · Markdown

Bexarotene

NDC 69238-1250 · HUMAN PRESCRIPTION DRUG · CAPSULE

Labeler / ManufacturerAmneal Pharmaceuticals NY LLC
Marketing categoryAbbreviated NDA (generic) · App ANDA210105
Dosage form / routeCAPSULE · ORAL
Active ingredientsBEXAROTENE (75 mg/1)
Marketing started20180904
Package count1

External sources

Source: openFDA. Public-domain (CC0).